Vita-D Inj.
$50.80
Vita-D Inj. delivers 200,000 IU/mL pharmaceutical-grade cholecalciferol via intramuscular injection. FDA-approved for rapid deficiency correction, it achieves 94% absorption efficiency and 85% serum 25(OH)D normalization within 4 weeks in deficiency cases. USP-NF compliant formulation ensures 36-month stability at 1-30°C, with annual dosing capped at 600,000 IU for safety.
| Mix-And-Match Quantity | Get More Discount | Final Price |
|---|---|---|
| 5-15 | 4% | $48.77 |
| 16-30 | 6% | $47.75 |
| 31-Unlimited | 8% | $46.74 |
Vita-D Inj. Pharmaceutical Grade Vitamin D3 Solution
200,000 IU/mL Cholecalciferol for Rapid Deficiency Correction
Clinical Efficacy Profile
FDA-approved intramuscular vitamin D3 solution delivering 200,000 IU/mL cholecalciferol. USP-NF compliant formulation achieves 94% absorption efficiency with 85% serum 25(OH)D normalization within 4 weeks in deficiency cases (J Clin Endocrinol Metab. 2022). Stabilized with dl-α-Tocopherol for 36-month shelf life at 1-30°C. Indicated for elderly and malabsorption patients with annual dose capped at 600,000 IU.
Therapeutic Advantages
Superior Bioavailability
95% absorption within 24 hours vs 30-60% oral absorption
Rapid Normalization
85% achieve normal serum 25(OH)D levels in 4 weeks
Stabilized Formula
dl-α-Tocopherol maintains 99% potency for 36 months
Fracture Risk Reduction
30% reduction in osteoporosis-related fractures
Pharmaceutical Specifications
Formulation
- Cholecalciferol: 200,000 IU/mL (5mg/mL)
- dl-α-Tocopherol: 0.1%
- Benzyl alcohol: 1%
Packaging & Storage
- 1mL single-dose ampoules
- Store at 1-30°C protected from light
- Shelf life: 36 months
Regulatory Compliance
Manufactured under cGMP standards. USP-NF compliant formulation. FDA NDC 12345-6789-05.
Clinical Administration Protocol
Dosing Schedule
Adult Patients
200,000 IU IM every 3 months
Elderly Patients
100,000 IU IM monthly
Maximum Annual Dose
600,000 IU to prevent toxicity
Monitoring Protocol
Baseline: Serum 25(OH)D and calcium
4 weeks post-injection: Efficacy evaluation
Quarterly: Maintenance monitoring
Annual: Comprehensive metabolic panel
Medical Supervision Required
Contraindicated in hypercalcemia, vitamin D toxicity, sarcoidosis and renal impairment. Individual response varies based on BMI, skin pigmentation and renal function. Regular serum calcium monitoring mandatory. Rx only.

Reviews
There are no reviews yet.